Softmax Co

Softmax Co R&D Expenses

The Research & Development Expenses of Softmax Co (3671.T) as of Oct 31, 2026 is 29.50 M JPY. In the previous year, Research & Development Expenses was 62.45 M JPY — a change of -52.76% (lower).

R&D Expenses

29.50 MJPY

YoY

-52.76%

Last updated:

Research & Development Expenses of Softmax Co is 2024 29.50 M JPY. Research & Development Expenses of Softmax Co was 2023 62.45 M JPY. It decreases by -52.76% lower compared to the previous year.

The Softmax Co R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2016
15.17 M JPY
Jan 1, 2017
25.33 M JPY
Jan 1, 2018
19.13 M JPY
Jan 1, 2019
8.15 M JPY
Jan 1, 2021
37.16 M JPY
Jan 1, 2022
24.71 M JPY
Jan 1, 2023
62.45 M JPY
Jan 1, 2024
29.50 M JPY
The Softmax Co R&D Expenses history
YEARR&D ExpensesYoY
29.50 MJPY-52.76%
62.45 MJPY+152.77%
24.71 MJPY-33.52%
37.16 MJPY+355.94%
8.15 MJPY-57.39%
19.13 MJPY-24.48%
25.33 MJPY+67.01%
15.17 MJPY-53.49%
32.60 MJPY+2,918.80%
1.08 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Softmax Co Stock analysis

What does Softmax Co do? Softmax Co., Ltd. generates revenue through system software, hardware, and maintenance services for medical institutions. The system software business offers electronic medical record systems, ordering systems, medical accounting systems, and department support systems like health examination and rehabilitation systems. Hardware business sells servers and PC terminals required for system operation. Maintenance services provide post-introduction user support, maintenance, and expendable supply sales. Medical institutions purchase these products to streamline hospital workflows and manage patient data efficiently. The company's system software includes electronic medical record systems, ordering systems, medical accounting systems, and department support systems such as health examination and rehabilitation systems. Hardware sales consist of servers and PC terminals. Maintenance services cover user support, system maintenance, and expendable supply sales. These offerings are tailored to hospitals and medical institutions seeking integrated solutions for healthcare management. Softmax Co., Ltd. serves medical institutions that require comprehensive medical information systems. The primary buyers are hospitals and healthcare facilities needing electronic health records, examination ordering, and medical accounting capabilities. The company's products help these institutions improve operational efficiency and patient care through streamlined workflows and centralized data management. Softmax Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Softmax Co stock

Research & Development Expenses of Softmax Co is 29.50 M JPY in 2024.

Research & Development Expenses of Softmax Co changed from 62.45 M JPY to 29.50 M JPY, representing a -52.76% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Softmax Co since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Softmax Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Softmax Co

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Softmax Co